Polar Capital LLP [Rocket]

Date Filed	Type	Description
02/14/2020	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020	SC 13G/A	Polar Capital LLP reports a 9.7% stake in Oxford Immunotec Global PLC
02/14/2020	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2019	SC 13G/A	Polar Capital LLP reports a 0% stake in AVEO Pharmaceuticals, Inc.
02/14/2019	SC 13G/A	Polar Capital LLP reports a 4.8% stake in Heritage Insurance Holdings, Inc.
02/14/2019	SC 13G/A	Polar Capital LLP reports a 9.7% stake in Oxford Immunotec Global PLC
02/14/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019	SC 13G	Polar Capital LLP reports a 9.1% stake in Stemline Therapeutics, Inc.
02/14/2018	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2018	SC 13G/A	Polar Capital LLP reports a 9.6% stake in Oxford Immunotec Global PLC
02/14/2018	SC 13G	Polar Capital LLP reports a 5.3% stake in Heritage Insurance Holdings, Inc.
02/14/2018	SC 13G	Polar Capital LLP reports a 6.8% stake in AVEO Pharmaceuticals, Inc.
02/14/2018	SC 13G/A	Polar Capital LLP reports a 4.4% stake in Achaogen, Inc.
03/06/2017	SC 13G	Polar Capital LLP reports a 7.6% stake in Oxford Immunotec Global PLC
03/06/2017	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2012	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals